Clinical Trials
3 trialsNCT07357623 2026-01-22
Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors
Shanghai Chest Hospital
Phase 2 Recruiting
NCT04579679 2025-07-25
Open-Label Surufatinib in European Patients With NET
Hutchmed
Phase 2 Terminated
NCT05165407 2025-03-14
NESSIE
Peking University
Phase 2 Recruiting